Entrectinib use in a platinum-refractory mucinous ovarian cancer harboring a NTRK3 gene fusion
Ovarian cancer is difficult to treat, and the mucinous epithelial subtype has a particularly poor response to traditional chemotherapy regimens. Entrectinib is a tumor-agnostic tyrosine kinase inhibitor with limited data regarding its use in ovarian cancers, though it demonstrates significant tumor...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2023-06-01
|
| Reeks: | Gynecologic Oncology Reports |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2352578923000565 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|